These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 7536155

  • 1. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy.
    Arcidiacono R, Gambitta P, Rossi A, Grosso C, Bini M, Zanasi G.
    Endoscopy; 1994 Nov; 26(9):715-8. PubMed ID: 7536155
    [Abstract] [Full Text] [Related]

  • 2. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
    Duvnjak M, Supanc V, Simicević VN, Hrabar D, Troskot B, Smircić-Duvnjak L, Bekavac-Beslin M.
    Acta Med Croatica; 1999 Nov; 53(3):115-8. PubMed ID: 10705631
    [Abstract] [Full Text] [Related]

  • 3. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP.
    Arvanitidis D, Hatzipanayiotis J, Koutsounopoulos G, Frangou E.
    Hepatogastroenterology; 1998 Nov; 45(19):248-52. PubMed ID: 9496522
    [Abstract] [Full Text] [Related]

  • 4. Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy.
    Hardt PD, Kress O, Fadgyas T, Doppl W, Schnell-Kretschmer H, Wüsten O, Klör HU.
    Eur J Med Res; 2000 Apr 19; 5(4):165-70. PubMed ID: 10799351
    [Abstract] [Full Text] [Related]

  • 5. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
    Sternlieb JM, Aronchick CA, Retig JN, Dabezies M, Saunders F, Goosenberg E, Infantolino A, Ionna S, Maislin G, Wright SH.
    Am J Gastroenterol; 1992 Nov 19; 87(11):1561-6. PubMed ID: 1279967
    [Abstract] [Full Text] [Related]

  • 6. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
    Thomopoulos KC, Pagoni NA, Vagenas KA, Margaritis VG, Theocharis GI, Nikolopoulou VN.
    Gastrointest Endosc; 2006 Nov 19; 64(5):726-31. PubMed ID: 17055865
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The value of serum amylase and elastase measurements in the prediction of post-ERCP acute pancreatitis.
    Kapetanos D, Kokozidis G, Kinigopoulou P, Xiarchos P, Antonopoulos Z, Progia E, Kitis G.
    Hepatogastroenterology; 2007 Mar 19; 54(74):556-60. PubMed ID: 17523321
    [Abstract] [Full Text] [Related]

  • 9. Controlled trial of different dosages of octreotide in the prevention of hyperamylasemia induced by endoscopic papillosphincterotomy.
    Testoni PA, Lella F, Bagnolo F, Buizza M, Colombo E.
    Ital J Gastroenterol; 1994 Dec 19; 26(9):431-6. PubMed ID: 7541258
    [Abstract] [Full Text] [Related]

  • 10. [Prevention of post-ERCP acute pancreatitis with octreotide].
    Baldazzi G, Conti C, Spotti EG, Arisi GP, Scevola M, Gobetti F, Agliardi CM, Galasso P, Bonomi E, Bianchi F.
    G Chir; 1994 Dec 19; 15(8-9):359-62. PubMed ID: 7803209
    [Abstract] [Full Text] [Related]

  • 11. Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis.
    Testoni PA, Bagnolo F, Caporuscio S, Lella F.
    Am J Gastroenterol; 1999 May 19; 94(5):1235-41. PubMed ID: 10235200
    [Abstract] [Full Text] [Related]

  • 12. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
    Li ZS, Pan X, Zhang WJ, Gong B, Zhi FC, Guo XG, Li PM, Fan ZN, Sun WS, Shen YZ, Ma SR, Xie WF, Chen MH, Li YQ.
    Am J Gastroenterol; 2007 Jan 19; 102(1):46-51. PubMed ID: 17266687
    [Abstract] [Full Text] [Related]

  • 13. Twenty-four-hour serum amylase predicting pancreatic reaction after endoscopic sphincterotomy.
    Testoni PA, Caporuscio S, Bagnolo F, Lella F.
    Endoscopy; 1999 Feb 19; 31(2):131-6. PubMed ID: 10223361
    [Abstract] [Full Text] [Related]

  • 14. The role of octreotide versus placebo in the prevention of post-ERCP pancreatitis.
    Kisli E, Baser M, Aydin M, Guler O.
    Hepatogastroenterology; 2007 Feb 19; 54(73):250-3. PubMed ID: 17419271
    [Abstract] [Full Text] [Related]

  • 15. Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography.
    Tulassay Z, Döbrönte Z, Prónai L, Zágoni T, Juhász L.
    Aliment Pharmacol Ther; 1998 Nov 19; 12(11):1109-12. PubMed ID: 9845400
    [Abstract] [Full Text] [Related]

  • 16. [Octreotide in the prevention of hyperamylasemia following ERCP (a controlled multicenter study)].
    Döbrönte Z, Juhász L, Tulassay Z.
    Orv Hetil; 1996 Oct 20; 137(42):2309-12. PubMed ID: 8992429
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
    Lee KT, Lee DH, Yoo BM.
    Pancreas; 2008 Nov 20; 37(4):445-8. PubMed ID: 18953260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.